Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eovist for Liver MRI in Infants 0-2 Months
NCT02084628Phase 3Terminated
- Sponsor
- Bayer
- Start
- Feb 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gadoxetate disodium in liver disease, sponsored by Bayer. Started Feb 2015; status: terminated.
02
Drugs
gadoxetate disodium
03
Conditions
liver disease
Beyond the preview
Go deeper on NCT02084628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02084628.